Infectious disease
The two companies were able to get their antibody candidate into the clinic within two months of announcing their collaboration in response to the global pandemic.
The San Francisco Business Times recently highlighted four women who are making strides in addressing the novel coronavirus in its “Influential Women of 2020” series.
In the lead-up to the ASCO Annual Meeting, companies were presenting some of their trial data, while other companies were presenting news related to COVID-19 studies. Here’s a look.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 1, 2020.
ViralClear Chief Executive Officer Nick Spring told BioSpace that the preclinical work is “telling a very good story.”
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 29, 2020.
The company is expanding its manufacturing efforts in Europe, Canada, the United Kingdom and the United States in order to meet this goal.
A protein called ACE2 is intimately involved in how SARS-CoV-2, the virus that causes COVID-19, infects the body.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 28, 2020.
PRESS RELEASES